Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Return to: PBR Home | Contract Research & Services
Today in Contract Research & Services

Contract Research & Services

AstraZeneca’s Zavicefta meets main goals in phase III trial to treat hospital-acquired pneumonia AstraZeneca has unveiled positive results from a phase III trial of its Zavicefta antibiotic, a fixed dose combination of two active substances, ceftazidime and avibactam. Contract Research & Services > Clinical Trials > News

Latest Contract Research & Services News by Sector

Select a sector from the list or browse by sector below:

Clinical Trials

Amgen unveils positive results from phase 3 study of Prolia in patients receiving glucocorticoid therapy
Amgen announced positive top-line results from the primary analysis conducted in a Phase 3 randomized, double-blind, double-dummy, active-controlled study evaluating the safety and efficacy of Prolia (denosumab) compared with risedronate in patients receiving glucocorticoid treatment.
Contract Research & Services > Clinical Trials > News
CTI BioPharma reports mixed results for pacritinib in advanced myelofibrosis
By PBR Staff Writer
CTI BioPharma announced that a phase 3 clinical trial of pacritinib for high-risk patients with advanced myelofibrosis met one of the co-primary endpoints.
Contract Research & Services > Clinical Trials > News

Contract Research

Biothera collaborates with Merck for combination cancer immunotherapy trials in multiple indications
Biothera Pharmaceuticals announced a collaboration with Merck to expand the companies’ ongoing clinical program evaluating KEYTRUDA (pembrolizumab), Merck’s anti-PD-1 inhibitor, in combination with Biothera’s Imprime PGG, a Pathogen Associated Molecular Patterning molecule, or PAMP.
Contract Research & Services > Contract Research > News
Xycrobe signs research deal with Johnson & Johnson Consumer
Xycrobe Therapeutics has entered into a research agreement with Johnson & Johnson Consumer.
Contract Research & Services > Contract Research > News

Contract Services

TaiGen out-licenses Taigexyn to Productos Cientificos for Latin American market
TaiGen Biotechnology Company has signed an exclusive licensing agreement with Mexican pharmaceutical firm Productos Científicos (PC) to develop and commercialize Taigexyn (nemonoxacin) in Latin America.
Contract Research & Services > Contract Services > News
Celsion, Zhejiang Hisun sign deal to develop GEN-1 immuno-oncology therapy
Celsion has signed a long-term Technology Transfer, Manufacturing and Commercial Supply Agreement with Zhejiang Hisun Pharmaceutical to pursue an expanded partnership for the technology transfer relating to the clinical and commercial manufacture and supply of GEN-1, Celsion's gene mediated, IL-12 immunotherapy, for the greater China territory, with the option to expand into other countries in the rest of the world after all necessary regulatory approvals are in effect.
Contract Research & Services > Contract Services > News